NSCLC research hub

Radiation During Osimertinib Treatment: a Safety and Efficacy Cohort Study

This study looks at whether it's safe and effective to continue a lung cancer drug called osimertinib (Tagrisso) while also having radiotherapy. It focuses on people with a specific type of lung cancer that has a particular genetic change.